Editas Medicine Navigates Volatility with Focus on Transformative Genome Editing Therapeutics
Editas Medicine, Inc. is a biotechnology company focused on developing transformative genome editing technologies for treating various diseases, despite recent stock volatility and a negative P/E ratio.
2 minutes to read